China Medicine Corporation (CHME) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for China Medicine Corporation (CHME).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $0.0₃5

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $569,090

Daily Volume: 0

Details

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.

Selected stocks

AMTRUST FINANCIAL SERVICES INC DEP SHS REPSTG 1/40TH PFD B (AFSIB)

AMTRUST FINANCIAL SERVICES INC 6.75% NON-CUM PFD SER A USD25 (AFSIA)

AMTRUST FINANCIAL SERVICES INC 7.625% DEP SHS EACH REP 1/40TH PFD SER C (AFSIC)